FTCM
APLS

First Trust Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

First Trust Capital Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-350,800
Closed -$14.1M – 164
2026
Q1 		$14.1M Buy
+350,800
New +$7.56M 0.74% 27

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

First Trust Capital Management's APLS Position: Q2 2026 in Review

First Trust Capital Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 350,800 shares — an estimated $14.1M sold.

First Trust Capital Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $14.1M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • First Trust Capital Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • First Trust Capital Management sold 350,800 Apellis Pharmaceuticals shares in Q2 2026, an estimated $14.1M.
  • First Trust Capital Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • First Trust Capital Management's Apellis Pharmaceuticals position peaked at $14.1M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on First Trust Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.